Chemoinformaics analysis of 2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-3-METHOXYCHROMEN-4-ONE
| Molecular Weight | 316.265 | nRot | 2 |
| Heavy Atom Molecular Weight | 304.169 | nRig | 18 |
| Exact Molecular Weight | 316.058 | nRing | 3 |
| Solubility: LogS | -3.642 | nHRing | 1 |
| Solubility: LogP | 2.494 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 40.3355 |
| nHD | 4 | BPOL | 16.3785 |
| QED | 0.535 |
| Synth | 2.493 |
| Natural Product Likeliness | 1.605 |
| NR-PPAR-gamma | 0.952 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.016 |
| HIA | 0.021 |
| CACO-2 | -5.011 |
| MDCK | 0.00000985 |
| BBB | 0.007 |
| PPB | 0.945182 |
| VDSS | 0.638 |
| FU | 0.0925092 |
| CYP1A2-inh | 0.962 |
| CYP1A2-sub | 0.666 |
| CYP2c19-inh | 0.098 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.613 |
| CYP2c9-sub | 0.845 |
| CYP2d6-inh | 0.557 |
| CYP2d6-sub | 0.295 |
| CYP3a4-inh | 0.451 |
| CYP3a4-sub | 0.084 |
| CL | 8.978 |
| T12 | 0.924 |
| hERG | 0.041 |
| Ames | 0.677 |
| ROA | 0.114 |
| SkinSen | 0.88 |
| Carcinogencity | 0.045 |
| EI | 0.934 |
| Respiratory | 0.123 |
| NR-Aromatase | 0.892 |
| Antiviral | Yes |
| Prediction | 0.788293 |